Clinical Trials
Engage with the leading edge of biopharmaceuticals

Clinical Trials

In July 2016 Bexion received a "Study May Proceed" letter from the FDA, allowing Bexion to initiate the first clincial trial using BXQ-350 to dose patients with cancer (solid tumors and glioblastoma).

Information about the Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors trial can be found at https://www.clinicaltrials.gov/show/NCT02859857

For more information about clinical trials:

http://www.fda.gov/Drugs/DevelopmentApprovalProcess/ConductingClinicalTrials/

http://www.cancer.gov/about-cancer/treatment/clinical-trials

https://www.clinicaltrials.gov/

Clinical Trials